[The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy / Q000201:enzymology; D009136:Muscular Dystrophies / Q000201:enzymology*; D009468:Neuromuscular Diseases / Q000175:diagnosis / Q000201:enzymology; D011115:Polyneuropathies / Q000201:enzymology*; D013997:Time Factors
D003402:Creatine Kinase
Die serum-creatin-phosphokinase-(CPK-)Aktivität bei amyotropher Lateralsklerose (ALS) und anderen neurogenen Muskelatrophien unter Berücksichtigung differentialdiagnostischer Aspekte.